Aristo Bio Tech and Lifescience Limited
NNSE:ARISTO88.20
INR
-1.10
(-1.23%)
ISIN
INE082101010
Return %
Stock
S&P 500
1Y
-34.67
14.20
3Y
5.95
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Narendra Singh Barhat
- Full Time Employees
- 66
- Sector
- Process industries
- Industry
- Chemicals: agricultural
- Address
- E-24, 25, 26, G.I.D.C., Manjusar, Ta. Savli Vadodara GU India 391775
- IPO Date
- Jan 30, 2023
- Website
- aristobiotech.com
- Similar Companies
- Business
- Aristo Bio-Tech and Lifescience Limited (ARISTO-SM.NS), an India-based agrochemical company founded in 2005 and headquartered at E-24-25-26, GIDC Estate, Manjusar, Vadodara, Gujarat, manufactures, formulates, supplies, packages and provides contract manufacturing job work services for pesticides and agrochemicals including insecticides such as Abamectin 1.9% EC, Acephate 75% SP and 95% SG, Alpha-Cypermethrin 5-10% EC/SC, Bifenthrin 2.5-10% EC/SC/CS, Chlorpyrifos 20-48% EC, Cypermethrin 5-40% EC, Emamectin Benzoate 5% SG and 1.9% EC, Fipronil 5% SC and 80% WG, Imidacloprid 30.5% SC and 70% WG, Lambda-Cyhalothrin 2.5-10% EC/WP/CS, Thiamethoxam 25% WG and 75% SG; herbicides and weedicides such as 2,4-D Amine Salt 58% SL and Ethyl Ester 38% EC, Atrazine 50-80% WP, Glyphosate 5-20.2% SL, Pendimethalin 30-38.7% EC/CS, Pretilachlor 50% EC; fungicides including Azoxystrobin 23% SC and various combinations with Tebuconazole, Carbendazim 50% WP, Mancozeb 75% WG/WP and 45.5% SC, Propiconazole 13.9% EC, Tebuconazole 25.9-38.39% EC/SC; and plant growth regulators such as Ethephon 39% SL, Gibberellic Acid 0.186% SP and Paclobutrazol 23-40% SC, with 257 products registered with CIB&RC for domestic sales across 20 Indian states and exports to over 15 countries including Australia, Bangladesh, Germany, Kenya, South Africa, UAE and Vietnam. The ISO 9001:2015-certified company serves Indian and multinational clients such as Syngenta India Ltd, UPL Sustainable Agro Solutions Ltd, Monsanto India Ltd, Jubilant Agri & Consumer Products Ltd and Meghmani Organics Ltd through its formulation and packaging facility equipped for separate production lines to prevent contamination. In FY25 ended March 2025, Aristo Bio-Tech reports revenue of Rs 318 crore, up 30% from Rs 245 crore in FY24, with profit after tax at Rs 4.06 crore amid capacity expansions that increased depreciation by Rs 1 crore; recent developments include securing agrochemical purchase orders worth over Rs 14 crore in September-October 2025 for execution by late October.